Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2023 Earnings Call Transcript

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2023 Earnings Call Transcript May 10, 2023

Jazz Pharmaceuticals plc misses on earnings expectations. Reported EPS is $3.95 EPS, expectations were $4.24.

Operator: Good day, and thank you for standing by. Welcome to the Q1 2023 Jazz Pharmaceuticals Earnings Conference Call. [Operator Instructions]. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Andrea Flynn, Vice...